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ABSTRACT 
Current knowledge suggests that laryngeal chemoreflexes (LCR) are involved in the 
occurrence of certain neonatal apneas/bradycardias, especially in the preterm newborn. 
While caffeine and/or nasal continuous positive airway pressure (nCPAP) are the most 
frequent options used for treating apneas in preterm newborns, their effects on LCR-
related apneas/bradycardias are virtually unknown. The aim of the present study was to 
test the hypothesis that caffeine and/or nCPAP decreases LCR-related 
cardiorespiratory inhibition in a preterm ovine model. Seven preterm lambs were born 
vaginally on gestational day 133 (normal gestation: 147 days) after intramuscular 
injections of betamethasone and mifepristone. Five days after birth, a chronic surgical 
instrumentation was performed to record states of alertness, electrocardiogram, 
systemic arterial pressure and electromyographic activity of a laryngeal constrictor 
muscle as well as to insert a transcutaneous, supraglottal catheter. Laryngeal 
chemoreflexes were induced in quiet sleep during 4 randomized conditions: 1) control 
(without caffeine or nCPAP); 2) nCPAP (5 cm H2O, without caffeine); 3) caffeine 
(10mg/kg infused intravenously in 30 minutes, without nCPAP); and 4) nCPAP + 
caffeine. While nCPAP consistently blunted the LCR-related apneas/bradycardias, the 
effect of caffeine was inconsistent and on average not significant. In addition, the effect 
of caffeine + nCPAP was less beneficial than nCPAP alone. In conclusion, our unique 
results show that, contrary to caffeine, nCPAP consistently improves LCR-related 
cardiorespiratory inhibition in preterm lambs. Beyond their potential physiological 
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significance, our results suggest that nCPAP may be superior to caffeine for treating 
neonatal apneas linked to LCR. 
KEYWORDS: Quiet sleep; apneas of prematurity; mifepristone; swallowing; arousal 
response 
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INTRODUCTION 
Laryngeal chemoreflexes (LCR) are a group of reflexes triggered by the contact 
between a liquid and the laryngeal mucosa and are primarily aimed at preventing 
tracheal aspiration (29, 39). In a mature mammal, including in the healthy full-term 
newborn, LCR include cough, deglutition and arousal (37). However, in the immature 
newborn mammal such as the preterm lamb, LCR rather encompass significant and, at 
times, life-threatening apneas, bradycardias and desaturations (38); treatment is 
currently unknown.  Relevance for the study of LCR pertains to their likely involvement 
in neonatal pathologies linked to abnormalities of cardiorespiratory control, such as 
apneas of prematurity (AOP) (29, 39). 
Apneas of prematurity represent a very frequent and worrisome pathology, which 
affects 50% of all newborns before 37 weeks of gestation and virtually all extremely 
premature infants born before 28 weeks of gestation (40). Though a number of AOP 
can be prevented by either avoiding triggers or prone positioning or can be halted by 
gentle cutaneous stimulations, further treatment is often needed (28). Caffeine and 
nasal CPAP (nCPAP) undoubtedly represent the mainstay of treatment for severe AOP. 
However, additional intervention in the form of nasal or even endotracheal intermittent 
positive pressure ventilation is sometimes necessary (42). Apneas of prematurity have a 
complex physiopathology, mainly related to immaturity of respiratory control (24). And 
while immature respiratory reflexes such as LCR are involved in some AOP in response 
to triggers such as laryngeal penetration of upper airway secretions or gastric refluxate 
or during milk or vitamin ingestion (29, 39), the effects of caffeine and/or nCPAP on 
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LCR-related cardiorespiratory events are virtually unknown. Very preliminary results on 
the effect of caffeine administered in a non-controlled manner in 3 preterm lambs 
suggested that caffeine prevents severe LCR-related cardiorespiratory events (38). The 
aim of the present study performed in our unique ovine preterm model was therefore to 
test the hypothesis that caffeine and/or nCPAP can prevent LCR-related 
cardiorespiratory events. 
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MATERIAL AND METHODS 
Animals 
Experiments were performed in seven preterm lambs with a postconceptional age of 
133 days (normal gestation: 147 days) and a mean birth weight of 3.11 kg (SD 0.61) 
(range: 2.14-4.24 kg). The protocol of the study was approved by the Ethics Committee 
for Animal Care and Experimentation of the Université de Sherbrooke. 
Preterm lamb model  
Seven preterm lambs were born vaginally on gestational day 133. An ultrasound to 
confirm pregnancy, as well as the number of lambs and their viability was performed a 
few days prior to induction of premature labor in all ewes. To induce premature labor, 
ewes first received two intramuscular injections of 12 mg betamethasone on gestational 
days 131 and 132 to stimulate lung surfactant maturation (11). Secondly, on gestational 
day 132, an intramuscular injection of mifepristone (RU 486, a progesterone receptor 
antagonist, 8 mg/kg) was administered to all ewes (15). Thereafter, ewe behavior was 
carefully monitored by video surveillance, followed by one or more vaginal examinations 
until lambing. Lambing occurred on average 30 hours (SD 3) (range: 26 - 36h) after 
mifepristone injection. Delivery was only assisted in case of dystocia to prevent fetal 
neurological distress. During the first 48h following birth, vital signs, including 
temperature, heart and respiratory rate, oxygen saturation, blood glucose level and 
weight were meticulously monitored. If needed to maintain normal vital signs, lambs 
were placed under a heated lamp, received reconstituted ewe’s colostrum or milk by 
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bottle or feeding tube. The presence of an experimenter 24h/24 during the first 48h was 
deemed necessary to perform these vital tasks, as well as for assisting the preterm 
lamb in its attempts at successful interactions with its mother. 
 
Chronic Instrumentation  
Chronic instrumentation was performed on the 5th day of life under general anesthesia 
(2% isoflurane, 30% N2O, balance O2), as recently described (8). Briefly, anesthesia 
was preceded by an intramuscular injection of ketamine (5 mg/kg), atropine sulfate (0.1 
mg/kg) and morphine (0.016 ml/kg) and an intravenous bolus (10 ml/kg) of Ringer’s 
lactate solution. One dose of ketoprofen (3 mg/kg) was also injected intramuscularly for 
analgesia and repeated if needed the next day. Antibiotics (5 mg/kg gentamicin and 50 
mg ampicillin, twice a day) were administered intramuscularly prior to surgery and daily 
thereafter.  
As previously described (8), two right-angled needle-electrodes (E7-12, Grass 
Technologies, West Warwick, RI, USA) were inserted into the parietal cortex directly 
through the skull for electrocorticogram (ECoG) recordings, while a third needle-
electrode (F-E2M, Grass Technologies) was inserted under the scalp as a ground. Eye 
movements (EOG) were recorded with two custom-built silver electrodes inserted 
subcutaneously next to the right eye socket. The electrocardiogram (ECG) was 
recorded with 2 needle-electrodes (F-E2M, Grass Technologies) inserted under the 
periosteum of the 5th rib, on both sides of the thorax, and directly glued on the ribs.  For 
electrical activity (EMG) recording, custom-designed bipolar electrodes, built from right-
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angled gold connectors (Sullins Connector Solution, Digi-Key Corporation, Thief River 
Falls, MN, USA), were inserted into both thyroarytenoid muscles (TA; a glottal 
constrictor) through the lateral aspect of the thyroid cartilage. Both electrodes were then 
glued on the external surface of the thyroid cartilage. A catheter was also introduced 
into the right carotid artery to monitor arterial blood pressure and blood gases. In 
addition, a supraglottal catheter was inserted transcutaneously to allow injection of 
liquids into the laryngeal vestibule (13). Finally, a plastic tubing (internal diameter 1 mm) 
was subcutaneously tunneled to the lamb’s back in order to connect the external part of 
the supraglottal catheter to our custom-built, radio telemetry-driven injector. Leads from 
each electrode and catheter were subcutaneously tunneled to a common exit on the 
lamb’s back. Post-operative care included antibiotics and daily flushing of the arterial 
catheter with heparin solution. Lambs were euthanized at the end of experiments by 
pentobarbital overdose (100 mg/kg). Correct electrode and catheter positioning was 
systematically verified at necropsy.  
 
Experimental equipment 
Ventilatory equipment 
Nasal CPAP was applied using the Infant Flow nCPAP system (Cardinal Health, Dublin, 
OH, USA) with heated (37°C), humidified air. A custom-built nasal mask, filled with 
dental paste (Examix, Servident, St-Laurent, Qc, CAN), was installed on the lamb’s 
muzzle to deliver nCPAP while enabling the lamb to open its mouth at will (5). 
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Recording equipment 
Lamb instrumentation was completed immediately before recordings. Elastic bands for 
respiratory inductance plethysmography (Respitrace, NIMS, Miami Beach, FL, USA) 
were installed around the thorax and abdomen to monitor respiratory movements and to 
assess lung volume variations qualitatively. Nasal CPAP values were continuously 
monitored from the nasal mask (RX104A pressure transducer, Biopac Systems, Goleta, 
CA, USA). A reflectance pulse oximeter sensor (Masimo Radical, Irvine, CA, USA) was 
attached at the base of the tail for continuous monitoring of oxygen hemoglobin 
saturation (SpO2) as well as pulse wave. Arterial blood gases were also measured in 
four lambs (IL 1306, Instrumentation Laboratory, Lexington, MA, USA) and corrected for 
rectal temperature of the lamb (1). Finally, the subcutaneous plastic tubing connected to 
the supraglottal catheter was attached to a custom-built, radio telemetry-driven injector, 
where liquids to be injected were warmed and maintained at the lamb’s body 
temperature. All recordings were performed using our custom-designed radio telemetry 
system (33) in order to obtain prolonged recordings in non-sedated lambs under the 
least possible restraining conditions. The raw EMG signals were rectified, integrated, 
and moving time averaged (100 ms). All parameters were continuously recorded on a 
PC using AcqKnowledge software (version 4.1; Biopac Systems, Goleta, CA, USA). 
Design of the study 
All preterm lambs were housed and cared for with their mother in our animal quarters 
until the experimental day. Polysomnographic recordings were performed on postnatal 
days 7 and 8 (n = 5) or postnatal days 8 and 9 (n = 2) and included simultaneous 
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recording of respiratory movements, states of alertness, TA EMG, ECG, systemic 
arterial blood pressure and SpO2. Accordingly, lambs were placed in a Plexiglas 
chamber (1.2 x 1.2 x 1m, corresponding to guidelines from the Canadian Council for 
Animal Care) and comfortably positioned on a mattress with minimal contention (under 
the constant presence of an experimenter near the lamb to prevent agitation and 
ambulation when it was connected to nCPAP). Arterial blood gases and pH were 
measured in four lambs before each of the four experimental conditions in order to 
eliminate the presence of baseline hypoxia, hypercapnia and/or a low pH, which have 
been shown to affect LCR (17, 18). Laryngeal chemoreflexes were induced by injection 
of 0.5 ml of hydrochloric acid (HCl, pH = 2, diluted in saline) or ewe milk via the 
supraglottal catheter during quiet sleep (QS). Both solutions were injected twice in 
random order during four experimental conditions: 1) control (without caffeine or 
nCPAP); 2) nCPAP (5 cm H2O, without caffeine; 3) caffeine (10mg/kg infused 
intravenously in 30 minutes, without nCPAP); and 4) nCPAP + caffeine. Due to the long 
half-life of caffeine in the newborn (2), the two experimental conditions involving caffeine 
had to be performed on the second recording day. On each day, the order of the 2 
experimental conditions (with and without nCPAP) was randomized. The supraglottal 
catheter was systematically flushed with 1 ml of saline between each injection of test 
solutions (dead space of the catheter 0.5 ml) and each lamb was given at least 15 min 
of recovery time between two injections. Events such as agitation, cough, arousal 
and/or full awakening were noted by an observer throughout the recordings. Finally, 
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plasma caffeine level was systematically measured at the end of the second recording 
day. 
 
Data analysis 
States of alertness 
Standard electrophysiological and behavioral criteria were used to define quiet sleep 
(QS) (31). Cortical arousal from QS was defined by the association of a change in 
ECoG (decrease in amplitude + increase in frequency) for 3 s or more, with at least two 
of the following modifications: a 10% increase in heart rate (HR) or change in 
respiratory rate (RR) or movement (21). Full awakening was defined when the lamb was 
still awake after 1 min (16). 
 
Laryngeal chemoreflexes 
Analysis of the LCR was performed as described previously within the first minute 
following each laryngeal injection (38). First, cardiorespiratory responses were 
assessed as follows. The percentage of decrease in HR [%Dec HR = (HRBL- HRmin) x 
100/HRBL] was calculated, with HRBL representing the baseline HR value averaged over 
30 s before challenge, and HRmin representing the minimal HR value observed during 
the first minute after the challenge. The %Dec SpO2 was calculated in the same 
manner. Any presence of bradycardia (defined by a %Dec HR > 33%) was noted, as 
well as the number of bradycardias and total summed duration of bradycardias. The 
presence of apneas (defined as at least two missed breaths relative to baseline 
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breathing) was also noted, including the number of apneas and their total summed 
duration. Moreover, any presence of desaturation was noted, as defined by a decrease 
in SpO2 of at least 4% or < 90%, as well as the minimal SpO2 (SpO2min). The 
percentage of increase (%Inc) in MAP was also noted. For all stimulations, the time 
duration between the moment of stimulation and the moment of HRmin, the onset of the 
first apnea, SpO2min and MAP occurrence (respectively HRmin, apnea, SpO2min and MAP 
occurrence times) were measured. In addition to cardiorespiratory responses, the 
following responses, usually considered to be protective against tracheal aspiration 
(29), were assessed. First, the number of swallows (defined as a brisk, high-amplitude, 
and short-duration TA EMG burst) (30) occurring within the first minute after laryngeal 
stimulation was tallied. Secondly, the number of coughs (including laryngeal expiratory 
reflexes, which could not be discerned from coughs in our study) was also inferred from 
visual observations, as well as analysis of TA EMG and respiratory inductance 
plethysmograph signals. Lastly, the presence of arousal or full awakening was noted. 
 
Statistical analysis 
Results were first averaged in each lamb and then averaged for the 7 lambs as a whole. 
Quantitative data were expressed as mean (SD), whereas qualitative binary data 
(arousal and awakening, yes/no) were expressed as relative frequency. Statistical data 
analyses were performed on raw data for all variables. Quantitative continuous data 
were analyzed through a general linear model 2-way ANOVA for repeated measures 
using PROC MIXED of the SAS software (version 9.1, Cary, NC), with treatment 
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(nCPAP and/or caffeine) and solutions (HCl or ewe milk) as the independent variables. 
Binary data were analyzed with a logistic regression model using the GENMOD 
procedure of the SAS software while count data (number of coughs, swallows) were 
analyzed by the Friedman’s test followed by the Wilcoxon‘s signed rank test, using the 
GraphPad Prism software (version 5.0, La Jolla, CA). Differences were deemed 
statistically significant if p < 0.05. In addition, given the relatively small number of 
studied lambs (related both to the complexity of the preterm ovine model and ethical 
constraints), it was decided to give full consideration to the presence of a significant 
trend, defined as p < 0.1. 
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RESULTS 
Premature lamb model 
Seven pregnant ewes were included in the study. Lambing occurred on average 30 (3) 
hours (range 26 - 36 h) after mifepristone injection, on gestational day 133. The total 
number of births was 12, including 6 females and 6 males with 5 ewes delivering twins 
and 2 ewes delivering a single lamb. Eleven of the twelve preterm lambs survived, with 
two lambs from the same litter needing resuscitation at birth due to severe dystocia. 
One of these twins was stillborn and could not be resuscitated. One lamb was found 
cyanotic and bradycardic 24h after birth (following a prolonged apnea of prematurity?), 
but was successfully resuscitated. All the other lambs did not require oxygen at birth 
and presented normal vital signs from birth to the last day of experimentation (Table 1). 
Lamb feeding initially began by presentation of the ewe's teat for a maximum of 5 
minutes at approximately every 2 hours and was followed, if needed, by supplemented 
bottle-feeding (ewe colostrum or milk). Two lambs were tube-fed during the first 24 
hours of life due to a poor sucking reflex. All lambs were self-sufficient in feeding after 
24 to 48 hours of life. 
  
Effects of nCPAP and/or caffeine treatment 
Baseline cardiorespiratory values 
Baseline cardiorespiratory values obtained in all 7 lambs and in each experimental 
condition are detailed in Table 2. Overall, nCPAP alone or combined with caffeine 
decreased RR and increased MAP as well as SpO2 (see Table 2 for details on specific 
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interactions). In addition, baseline arterial blood gases and pH measured in 4/7 lambs 
were found normal in all experimental conditions: PaO2 = 80 (4) mmHg (range 76-88 
mmHg); PaCO2 = 41 (2) mmHg (range 39-45 mmHg); pH = 7.36 (0.01) (range 7.34-
7.37). 
Laryngeal chemoreflexes 
A total of 111 laryngeal stimulations were performed during QS; one LCR (milk) was not 
induced as one caffeine-treated lamb was unable to sleep during the recording. Plasma 
caffeine level in the 7 lambs was 58 (6) mg/L (range 35-67 mg/L) after completion of the 
second recording session, approximately 4 hours after caffeine infusion. 
Life-threatening cardiorespiratory events were observed in 3/7 lambs following HCl 
injection in control, caffeine and nCPAP/caffeine conditions. These events included 
repetitive, prolonged central apneas or periodic breathing epochs with bradycardias 
(minimum HR 32 beats/min) and hemoglobin desaturation (minimum SpO2 = 20%). The 
events lasted from 95 sec to 9 min before spontaneous recovery (Fig. 1). No severe 
cardiorespiratory event was observed under nCPAP condition in any of the lambs. 
Laryngeal chemoreflexes-related cardiorespiratory events. Cardiorespiratory 
events obtained during LCR are summarized in Figure 2 and Table 3, and are illustrated 
by tracings obtained in one lamb in the 4 experimental conditions in Figure 3. SpO2 was 
analyzed in only 5 lambs due to technical difficulties (one black lamb, hence the 
reflectance sensor unable to analyze blood color, and one lamb with its tail severely 
bitten by the ewe). Overall, nCPAP significantly blunted the LCR-related 
cardiorespiratory components elicited by HCl compared to control and to caffeine 
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treatment. A beneficial effect of nCPAP treatment was observed for apnea number 
and/or duration, as well as for bradycardia number and/or duration and for the %Dec 
HR. In addition, minimal HR and SpO2 values were higher during nCPAP treatment (see 
Table 3 for details on specific interactions). Although cardiorespiratory inhibition was 
less pronounced following milk injection, it was similarly blunted under nCPAP treatment 
compared to control and caffeine treatment (Table 3). By contrast, caffeine alone or 
when combined with nCPAP had no significant effect, on average, on LCR-related 
cardiorespiratory inhibition. Further analysis revealed that, contrary to nCPAP, the effect 
of caffeine was notably variable from one lamb to another for apnea number and/or 
duration (Fig. 4A), as well as for bradycardia number and/or duration for both HCl (Fig. 
4B) and milk. 
Protective mechanisms observed during laryngeal chemoreflexes. The protective 
mechanisms observed during LCR are summarized in Table 4. Overall, the %Inc MAP 
was decreased during nCPAP and nCPAP + caffeine treatment compared to control, 
independently of the solution used to induce the LCR. While no differences between 
treatments for either solutions were observed for awakening, a greater number of 
arousals was noted during nCPAP + caffeine treatment compared to control, following 
HCl injection only (p = 0.05). Finally, while no differences between treatments were 
noted for the number of swallows, a greater number of coughs were observed after 
caffeine administration when compared to nCPAP alone or combined with caffeine 
following HCl injection only, whereas no differences were otherwise noted between 
treatments and control condition. 
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DISCUSSION 
Statement of principal findings 
The present study provides new and intriguing findings on the effects of nCPAP and/or 
caffeine on laryngeal chemoreflexes in preterm lambs. Indeed, nCPAP blunted LCR-
related cardiorespiratory inhibition, contrary to caffeine alone or combined with nCPAP; 
minimal effects were noted on the so-called protective mechanisms such as swallowing, 
coughs, arousal responses and awakenings. Moreover, while the effects of nCPAP 
treatment on cardiorespiratory events were consistent in most lambs (6/7 lambs), the 
effect of caffeine was notably variable from one lamb to another. 
 
Our preterm lamb model 
Over the years, many improvements have been made to our preterm lamb model, which 
has resulted in an important increase in the survival rate and health outcome of our 
animals (3, 30, 31, 38). Previously, intensive neonatal care, including delivery by 
caesarean section under epidural anesthesia, immediate endotracheal intubation at 
birth to deliver exogenous surfactant replacement, supplemental nasal oxygen and tube 
feeding, were applied, with an average survival rate of roughly 50% at day 7 of life (3, 
30, 31, 38). In contrast, 11/12 preterm lambs delivered in the present study survived 
(one stillborn lamb due to severe dystocia) with constant care focusing on optimal ewe-
lamb interactions during the first 48 hours of life while eliminating invasive procedures. 
This intensive, albeit non-invasive neonatal care probably explains our high survival rate 
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(> 90%), which compares favorably to the rates recently reported by others for a similar 
preterm ovine model (9). 
 
Effects of caffeine and/or nCPAP treatment on laryngeal chemoreflexes 
Caffeine is undoubtedly the first line treatment for severe AOP, due to both its general 
efficiency in reducing AOP and its relative short term and long term safety profile, 
including up to school-age (2, 25, 34, 35). Caffeine is both a powerful central nervous 
system stimulant and respiratory stimulant. The latter is partly related to its potent A1 
and A2 adenosine receptor antagonist action and includes an increase in minute 
ventilation and CO2 sensitivity as well as a decrease in hypoxic depression and periodic 
breathing (23). However, caffeine alone can be insufficient to treat AOP (6) and nCPAP 
(4-6 cmH20) must often be added to caffeine for an optimal effect on AOP. Nasal CPAP 
functions by decreasing upper airway obstruction and work of breathing and by 
increasing functional residual capacity and pulmonary oxygen stores (10, 24, 42). 
However, although nCPAP and caffeine are widely used for AOP treatment, their effects 
on LCR-related apneas and bradycardias are still unknown.  
Blunting of LCR-related cardiorespiratory inhibition by nCPAP 
Nasal CPAP increases laryngeal opening in preterm infants (14) and decreases non-
nutritive swallowing frequency in newborn lambs (32). This could conceivably increase 
the contact time of liquid with the laryngeal mucosa and consequently enhance LCR-
related cardiorespiratory inhibition. On the contrary, the present study reveals that an 
nCPAP of 5 cmH2O blunts LCR-related cardiorespiratory events and arterial oxygen 
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desaturation in preterm lambs, as opposed to caffeine alone or combined with nCPAP. 
The increase in pulmonary oxygen stores under nCPAP likely contributed to preventing 
desaturations and bradycardias following LCR-related apneas (10, 24). However, the 
mechanism underlying the beneficial effects of nCPAP on apneas is unclear. In 
particular, nasal CPAP did not decrease swallowing activity, a well-known respiratory 
inhibitor. 
High variability of caffeine effects on LCR-related cardiorespiratory inhibition 
Previous preliminary results in only 3 preterm lambs treated with caffeine (one 
intravenous infusion of 10 mg/kg) for clinically significant apneas and bradycardias, 3 
days prior to LCR studies, led to the hypothesis that caffeine treatment was an efficient 
means to prevent LCR-related cardiorespiratory events (38). However, results from the 
present study show a very variable effect of caffeine, with a blunting of the LCR-related 
cardiorespiratory inhibition being observed in only 2/7 preterm lambs (figure 4). Such 
variable effect of caffeine has also been reported in preterm infants for AOP reduction 
(12, 19, 26), as well as a failure to prevent hypoxemic episodes and bradycardias (7). 
Of note, the variability in caffeine effect in preterm lambs was not related to a variable 
arousal and/or awakening response during LCR, since the latter did not differ between 
treatments. 
Protective mechanisms related to laryngeal chemoreflexes 
Aside from cardiorespiratory events, laryngeal chemoreflexes also elicit coughing, 
swallowing, arousal and awakening. These components of the LCR are considered to 
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be protective mechanisms aimed at both clearing liquids from the laryngeal region and 
preventing tracheal aspiration. The absence of effects of nCPAP on swallowing during 
LCR may appear surprising, given our previous report that non-nutritive swallowing is 
decreased by nCPAP via reflexes originating from bronchopulmonary receptors (32). 
However, our recent study showing that nCPAP (up to 10 cmH20) does not decrease 
nutritive swallowing (5) likely indicates that the inhibiting effect of nCPAP on swallowing 
does not operate in instances of urgency, when repetitive swallowing is deemed crucial 
by the swallowing centers to prevent tracheal aspiration. To our knowledge, there have 
been no previous reports of the effect of caffeine on swallowing. 
While in the present study, the administration of caffeine increased the number of 
coughs when compared to nCPAP alone or combined with caffeine, the precise 
mechanism underlying this effect remains unclear. Finally, while the positive effect of 
nCPAP/caffeine on arousal may seem in agreement with the well-known neurostimulant 
effect of caffeine, including in human infants (4), the absence of any effect of caffeine 
alone remains unexplained. 
 
Clinical implications 
The present results, although obtained in lambs, suggest that nCPAP treatment is 
especially relevant for AOP related to LCR, as observed in preterm infants with 
laryngeal penetration of upper airway secretions or gastric refluxate. However, among 
infants presenting with AOP, the proportion suffering from LCR-induced 
cardiorespiratory events is currently unknown (27, 36). In addition, two important 
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questions need to be addressed and relate to the effects of nCPAP on the number and 
characteristics of gastric refluxes and on cardiorespiratory reflexes originating from 
esophageal receptors in instances of esophageal distension (20). Moreover, it is 
noteworthy that while nCPAP markedly reduces gastric reflux frequency in adult 
humans with obstructive sleep apneas (22), nCPAP has been shown to increase the 
gastroesophageal pressure gradient, and thus the risk of gastric refluxes, in adult rats 
(41). 
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FIGURE LEGENDS 
 
Figure 1 
Potentially life-threatening cardiorespiratory reflexes triggered in one preterm lamb 
following instillation of 0.5 ml HCl onto the laryngeal mucosa during quiet sleep in 
control condition (no nCPAP / no caffeine). From top to bottom: ECoG, 
electrocorticogram; EOG, electrooculogram; TA, electrical activity of the thyroarytenoid 
muscle (laryngeal constrictor); Lung volume, sum signal of the respiratory inductance 
plethysmograph, allowing qualitative measurement of respiration (inspiration upward); 
ECG, electrocardiogram; HR, heart rate (mean and maximum (max); beats/min); SpO2, 
hemoglobin O2 saturation; AP, arterial pressure (mean and maximum (max); mmHg). 
Note the prolonged, potentially life-threatening responses with awakening, repetitive 
apneas followed by periodic breathing, severe bradycardia down to 71 beats/min, and 
severe hemoglobin O2 desaturation down to 69%. 
 
Figure 2 
Effect of nCPAP and/or caffeine treatment on A: apnea number and duration; B:  
bradycardia number and duration; C: the % decrease in SpO2, following instillation of 
0.5 ml of milk (black column) and HCl (gray column) onto the laryngeal mucosa during 
quiet sleep. Values are expressed as means (standard deviation). **P < 0.05; *P<0.1.  
Apnea and bradycardia duration represents the sum of duration of all LCR-related 
apneas or bradycardias observed. 
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Figure 3 
Cardiorespiratory reflexes triggered in one preterm lamb following instillation of 0.5 ml 
HCl onto the laryngeal mucosa during quiet sleep in the four conditions studied (control, 
nCPAP, caffeine, nCPAP + caffeine). See abbreviations in figure 1. Arterial blood O2 
saturation could not be recorded because the lamb was black, hence blood color could 
not be analyzed by the reflectance pulse oximeter sensor. Note the severe LCR-related 
cardiorespiratory components with repetitive apneas, bradycardia and increased arterial 
pressure observed in control condition, as well as with caffeine and nCPAP + caffeine. 
 
Figure 4 
Individual cardiorespiratory responses following instillation of 0.5ml HCl on A: apnea 
duration; B: bradycardia duration. Note the high variability of the effect of caffeine (left 
column) from one lamb to another, compared to the much more consistent effect of 
nasal CPAP (right column). 
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TABLES 
Table 1: Mean baseline vital signs of the 7 preterm lambs during room air 
breathing from birth to the last day of experimentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as mean (standard deviation) 
 
 
Vital signs Values 
Heart rate (beats/min) 225 (7) 
Respiratory rate (breaths/min) 69 (5) 
Hemoglobin O2 saturation (%) 97 (0.5) 
Body temperature (oC) 39.9 (0.1) 
Glucose (mmol/l) 5.7 (2.4) 
Mean weight gain/day (g) 227 (72) 
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Table 2: Influence of nCPAP and/or caffeine treatment on baseline cardiorespiratory values during quiet 
sleep in 7 preterm lambs 
 
Baseline values Control nCPAP Caffeine nCPAP + caffeine 
Heart rate (beats/min) 182 (28) 195 (33) 186 (39) 188 (34) 
Respiratory rate (breaths/min) 60 (1) 52 (0) a,b 61 (2) 55 (1) b 
Mean arterial pressure (mmHg) 64 (13) 74 (13) a,b 64 (12) 69 (13) a 
Hemoglobin O2 saturation (%) 94 (1) 96 (0) a 94 (1) 96 (1) a,b 
Values are expressed as means (SD). Bold exponents indicate P < 0.05, normal font exponents indicate P < 0.1. 
All other P values are greater than 0.1.  a: vs. control, b: vs. caffeine, c: vs. nCPAP/caffeine. 
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Table 3: Effects of nCPAP and/or caffeine treatment on the cardiorespiratory components of LCR during 
quiet sleep in 7 preterm lambs 
 
 
Control nCPAP Caffeine nCPAP + caffeine 
 
Milk HCl Milk HCl Milk HCl Milk HCl 
% Decrease HR  38 (18) 44 (22) 30 (14) b,c 35 (15) a,b 42 (16) 50 (19) 39 (21) 39 (21) b 
Minimal HR, beats/min-1 126 (38) 121 (53) 152 (32) a,b 145 (34) a,b 122 (40) 105 (51) 132 (54) 128 (43) b 
HRmin occurrence time, s 11 (8) 20 (14) 8 (6) 12 (10) 7 (3) 20 (13) 13 (10) 18 (11) 
Apnea occurrence time, s 4 (5) 14 (12) 3 (5) 24 (25) 7 (7) 15 (9) 10 (13) 18 (12) 
SpO2min  87 (7) 87 (5) 94 (3) a,b 92 (5) a,b 89 (6) 87 (4) c 92 (3) a 91 (7) a 
SpO2min occurrence time, s 27 (15) 29 (15) 19 (7) 22 (8) b 19 (5) 37 (10) 18 (2) a 20 (9) b 
 
Variables are expressed as means (SD). HR, heart rate; HRmin, minimal heart rate; SpO2, hemoglobin O2 
saturation; SpO2min, minimal hemoglobin O2 saturation. a: vs. control, b: vs. caffeine, c: vs. nCPAP/caffeine. Bold 
exponents indicate P < 0.05, normal font exponents indicate P < 0.1. All other P values are greater than 0.1. 
34 
 
Table 4: Effects of nCPAP and/or caffeine treatment on the protective mechanisms of LCR during quiet 
sleep in 7preterm lambs 
 
 
     Control      nCPAP    Caffeine nCPAP + caffeine 
 
Milk  HCl Milk  HCl Milk  HCl Milk  HCl 
%Increase MAP  21 (7) 21 (6) 12 (3) a,b 14 (4) a,b 26 (20) 22 (8) 16 (5) b 14 (6) a,b 
MAP occurrence time, s 7 (3) 18(13) 10 (10) 11 (9) a,b,c 6 (3) 19 (8) 6 (1) 21 (12) 
No. swallows 10 (5) 11(9) 9 (4) 9(6) 11 (5) 16 (13) 10 (3) 12 (6) 
No. coughs 0.07 (0.1) 2(2) 0.3 (0.9) 1(1) b 1 (2) 5 (5) 0.2 (0.3) 2 (3) b 
No. arousals 11/111 6/111 12/111 9/111 6/111 6/111 11/111 11/111 a 
No. awakenings 0/111 4/111 0/111 2/111 4/111 6/111 0/111 1/111 
Quantitative variables are expressed as means (SD) and qualitative variables (arousal and awakening) are 
expressed as relative frequency. MAP, mean arterial pressure; No. arousals, number of LCR with arousal/total 
number of LCR; No. awakenings, number of LCR with awakening/total number of LCR. a: vs. control, b: vs. caffeine, 
c: vs. nCPAP/caffeine. Bold exponents indicate P < 0.05, normal font exponents indicate P < 0.1. All other P values 
are greater than 0.1. 
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FIGURES 
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Figure 2: 
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Figure 3: Effects of nCPAP and/or caffeine treatment on the cardiorespiratory components of LCR during QS 
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Figure 4: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
